Family Medicine · Grand Island, NE
NPI
1750949707
Since 2019
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3563 Prairieview St Ste 300
Grand Island, NE, 68803
Phone (308) 381-0162
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
4,754 services
Medicare patients, 2024
378
Average age 72
Drug cost, 2024
$611K
6,525 prescriptions
Company payments, 2025
$641
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas L Vonderfecht was code 99214 (office e&m - established), 577 times for 294 patients. In total Thomas L Vonderfecht billed 4,754 services in 101 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 577 | 294 | $80.58 | $46K |
| 36415 Venipuncture Blood Collection | Office | 478 | 236 | $8.60 | $4,111 |
| 80053 Clinical Chemistry | Office | 367 | 222 | $10.19 | $3,741 |
| 85025 Blood Count | Office | 336 | 207 | $7.51 | $2,522 |
| 80061 Clinical Chemistry | Office | 196 | 175 | $13.03 | $2,555 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 152 | 152 | $121.67 | $18K |
| 83036 Blood Count | Office | 116 | 73 | $9.46 | $1,097 |
| 99213 Office E&M - Established | Office | 98 | 87 | $53.22 | $5,216 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 95 | 14 | $42.54 | $4,042 |
| 81001 Clinical Chemistry | Office | 92 | 63 | $3.08 | $283 |
| 84443 Clinical Chemistry | Office | 89 | 77 | $16.25 | $1,446 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | Office | 86 | 86 | $18.70 | $1,608 |
| 84439 Clinical Chemistry | Office | 60 | 52 | $8.82 | $529 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 56 | 11 | $0.50 | $27.97 |
| 71046 X-ray - Chest | Office | 48 | 42 | $20.97 | $1,006 |
By year: 2022 $50K for 1,762 services; 2023 $120K for 3,856 services; 2024 $133K for 4,754 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 478 | 236 | $8.60 | $4,111 |
| 80053 Clinical Chemistry | 367 | 222 | $10.19 | $3,741 |
| 85025 Blood Count | 336 | 207 | $7.51 | $2,522 |
| 80061 Clinical Chemistry | 196 | 175 | $13.03 | $2,555 |
| 83036 Blood Count | 116 | 73 | $9.46 | $1,097 |
| 81001 Clinical Chemistry | 92 | 63 | $3.08 | $283 |
| 84443 Clinical Chemistry | 89 | 77 | $16.25 | $1,446 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 86 | 86 | $18.70 | $1,608 |
| 84439 Clinical Chemistry | 60 | 52 | $8.82 | $529 |
| 82043 Clinical Chemistry | 44 | 40 | $5.57 | $245 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas L Vonderfecht prescribed most often to Medicare patients was Atorvastatin Calcium, with 304 prescriptions and refills. In total Thomas L Vonderfecht wrote 6,525 Medicare prescriptions that cost $611K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 304 | 775 | 80 | $3,550 |
| Amlodipine Besylate Generic | 196 | 473 | 55 | $1,663 |
| Levothyroxine Sodium Generic | 178 | 413 | 40 | $1,892 |
| Metoprolol Succinate Generic | 165 | 351 | 40 | $3,353 |
| Gabapentin Generic | 162 | 227 | 31 | $4,064 |
| Meloxicam Generic | 159 | 312 | 58 | $871 |
| Omeprazole Generic | 148 | 369 | 38 | $2,605 |
| Rosuvastatin Calcium Generic | 145 | 409 | 43 | $1,352 |
| Metformin Hcl Generic | 145 | 295 | 32 | $1,408 |
| Losartan Potassium Generic | 141 | 363 | 40 | $1,169 |
| Lisinopril Generic | 123 | 244 | 25 | $1,024 |
| Tamsulosin Hcl Generic | 122 | 288 | 34 | $1,660 |
| Hydrochlorothiazide Generic | 114 | 319 | 37 | $300 |
| Pantoprazole Sodium Generic | 106 | 214 | 27 | $1,373 |
| Allopurinol Generic | 105 | 251 | 23 | $1,180 |
Brand drugs: 859 claims; generic drugs: 5,628 claims; opioid claims: 139.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas L Vonderfecht $641 ($641 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $297.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 38 | $297 |
| Abbott Laboratories ABT | 4 | $97.12 |
| Novo Nordisk Inc NVO | 3 | $45.72 |
| Madrigal Pharmaceuticals MDGL | 1 | $33.89 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $30.79 |
| Optinose US, Inc. | 1 | $24.39 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $23.46 |
| Merck Sharp & Dohme LLC MRK | 1 | $21.05 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $19.54 |
| Lilly USA, LLC LLY | 1 | $17.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.